K
KLA Corporation
KLAC · Technology
Q2 FY2026
Earning ended Dec 31, 2025Report generated Mar 10, 2026
The Tollbooth Gets Better — But You're Already Paying Peak Toll
Most investors debate whether China exposure is manageable, but the more consequential insight runs the other direction: KLA's revenue per wafer structurally compounds as chip complexity escalates, meaning the business is getting more valuable per dollar of fab capex even if geography stays flat — the problem is the market worked this out before most investors did.
Flowly Score
Apr 16 Close
-45%$1,734.85
Fair Value
$950.00
60
Averageat $1,734.85
Business Strength9/10
KLA operates the closest thing to a tollbooth in chip manufacturing — defect inspection is non-negotiable, switching costs compound with every node, and their EUV mask inspection position is effectively a monopoly forged from physics that no competitor has cracked at production scale. The moat widens with each successive node because harder manufacturing makes KLA's expertise more valuable, not less.
Financial Resilience9/10
Cash conversion is pristine across the full cycle — net income maps to operating cash flow without exception, and FCF margins above thirty percent on trivial CapEx reveal a business that funds itself and then some. A Piotroski of 8/9 and an Altman Z north of thirteen are the quantitative confirmation of what the business model already tells you qualitatively.
Growth & Trajectory7/10
The structural engine is real — inspection intensity per wafer rises with every node transition, advanced packaging market share has quintupled in four years, and HBM is accelerating DRAM process control intensity in ways that trailing revenue doesn't yet capture. The friction is near-term: 2026 is supply-constrained, China remains a live variable, and management's 'remarkable 2027' framing means investors are being asked to underwrite a growth inflection one year out.
Valuation3/10at $1,429.10
The DCF math is unambiguous — the neutral scenario produces a fair value roughly half the current price, and the optimistic scenario, which demands exceptional compounding for a full decade, barely reaches current levels. The quality premium is real, but the market has already priced not just the tollbooth but the next three expansion lanes.
Risk4/10
The China concentration is binary in a way most risks aren't — export controls could wipe a third of the revenue base in a regulatory cycle, with no geographic substitute at that scale waiting to absorb it. That single variable has the power to move fair value in both directions more than any operating factor, and the current geopolitical trajectory is not moving toward deescalation.
KLA is genuinely exceptional — a near-monopoly at the chokepoint of semiconductor manufacturing with software-like economics, pristine cash conversion, and a moat that widens as the very technology trends threatening cyclicality simultaneously make its tools more indispensable. The tension for new investors is that the market has not overlooked this. The current multiple prices in sustained margin excellence and a decade of above-average growth, which leaves almost no cushion for the business to deliver good — rather than exceptional — results. The structural trajectory justifies optimism about where the business is heading. Gate-all-around transistors, HBM, and heterogeneous integration multiply the inspection touchpoints per wafer in ways that trailing revenue numbers can't fully capture. The services layer compounding on a growing installed base creates annuity revenue that moderates downside even through capex corrections. Management's consistent emphasis on 2027 as an inflection year, combined with current supply constraints limiting shipments rather than demand, signals pent-up growth rather than structural deceleration. The single biggest risk is a broad expansion of U.S. export controls to cover mature-node equipment and active service contracts in China. Advanced-node restrictions have been navigated with meaningful revenue intact, but a sweeping extension to legacy nodes — the category most Chinese chipmakers are building — would simultaneously compress the near-term FCF base and invalidate the growth assumptions underwriting the premium multiple. No other geography can absorb that displacement at scale, and no amount of inspection intensity compounding at leading-edge nodes fills a hole that large in the near term.